Automatic Injectors Professional Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Automatic Injectors Professional Market covers analysis By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies); Type (Disposable Autoinjectors, Reusable Autoinjectors); Route of administration (Subcutaneous, Intramuscular); End User (Home Care Settings, Hospitals and Clinics, Ambulatory Care Settings) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00024680
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Automatic Injectors Professional Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

MARKET OVERVIEW

An automatic injector is a syringe with a pre-charged dose of medicines and a spring-charged needle. When inserted into the body with a sliding motion, the device activates and administers a measured dosage of a medicament. Autoinjectors are routinely used for self-administration of epinephrine (to avoid anaphylaxis), migraine patients (for rapid pain relief), and medical and emergency treatments. Auto-injectors have a number of advantages, including reducing needle-related phobia condition, reducing the risk of needle-stick incidents, maintaining dose quality consistency, and helping with increased effectiveness.

MARKET SCOPE

The Global Automatic Injectors Professional Market Analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the automatic injectors professional market with detailed market segmentation by therapy, type, route of administration and end user. The report provides key statistics on the market status of the leading automatic injectors professional market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on therapy the market is segmented as, RA, multiple sclerosis, diabetes, anaphylaxis, other therapies.
  •   Based on type the market is segmenetd as, disposable autoinjectors, resusable autoinjectors.
  •   Based on route of administration the market is segmenetd as, subcutaneous and IM.
  •   Based on end user the market is segmenetd as, home care setting, hospitals and clinics, ambulatory care settings.

MARKET DYNAMICS
Drivers:

  •   Growing cases of anaphylaxis disorders and other chronic diseases.
  •   Rising trend for self administration of medicaments due to growth in demand for homecare settings.
  •   Consistent R&D efforts for developing simple, cost-effective, and innovative technology-based autoinjectors for the treatment of chronic diseases such rheumatoid arthritis and multiple sclerosis are likely to fuel market growth throughout the forecast period.
  •   Increasing number of new product approvals and new product launches are also expected to spur market growth.

Restraints:

  •   However, availability of alternative treatment options is expected to restrain market growth during the forecast period.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The automatic injectors professional market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the automatic injectors professional market in these regions.

IMPACT OF COVID-19 ON AUTOMATIC INJECTORS PROFESSIONAL MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Automatic Injectors Professional Market Report Analysis

Automatic Injectors Professional Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Eisai Co., Ltd
  • Viatris Inc
  • Ypsomed
  • Amgen, Inc
  • BD
  • Teva Pharmaceuticals USA, Inc
  • Antares Pharma
  • Merck KGaA
  • Owen Mumford

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

By Therapy
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Diabetes
  • Anaphylaxis
  • Other Therapies
By Type
  • Disposable Autoinjectors
  • Reusable Autoinjectors
By Route of administration
  • Subcutaneous
  • Intramuscular
By End User
  • Home Care Settings
  • Hospitals and Clinics
  • Ambulatory Care Settings
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS


The report covers key developments in the automatic injectors professional market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from automatic injectors professional market are anticipated to lucrative growth opportunities in the future with the rising demand for Automatic injectors professional in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the automatic injectors professional market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Eisai Co., Ltd
  •   Viatris Inc
  •   Ypsomed
  •   Amgen, Inc
  •   BD
  •   Teva Pharmaceuticals USA, Inc
  •   Antares Pharma
  •   Merck KGaA
  •   Owen Mumford
  •   Biogen
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Automatic Injectors Professional Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Therapy
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Diabetes
  • Anaphylaxis
  • Other Therapies
By Type
  • Disposable Autoinjectors
  • Reusable Autoinjectors
By Route of administration
  • Subcutaneous
  • Intramuscular
By End User
  • Home Care Settings
  • Hospitals and Clinics
  • Ambulatory Care Settings
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Eisai Co., Ltd
  • Viatris Inc
  • Ypsomed
  • Amgen, Inc
  • BD
  • Teva Pharmaceuticals USA, Inc
  • Antares Pharma
  • Merck KGaA
  • Owen Mumford
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Eisai Co., Ltd
    2. Viatris Inc
    3. Ypsomed
    4. Amgen, Inc
    5. BD
    6. Teva Pharmaceuticals USA, Inc
    7. Antares Pharma
    8. Merck KGaA
    9. Owen Mumford
    10. Biogen

    Trends and growth analysis reports related to Medical Device : READ MORE..